- Uncontrollable stress in healthcare workers may be a legal hazard, researchers argue
- Baptist Health Richmond names chief medical officer
- 101 hospital and health system chief pharmacy officers to know | 2026
- 21 new behavioral health study findings to know
- 32 behavioral health executive moves to know
- 7 Medicaid behavioral health fraud cases, audit findings to know
- Beyond alarm management: How Elizabeth Seton Children’s Center turned surveillance data into personalized pediatric care
- What’s next for Rush’s retiring CEO
- Healthcare billing fraud: 10 recent cases
- Assort Health raises $120M
- HCA Florida hospital taps COO
- 48 recent hospital, health system executive moves
- How long does it take to sell an ASC?
- Why 34 health systems bet big on GI in 2026
- Lung cancer screening, mortality and incidence — by state
- My Community Dental Centers appoints new CEO
- 42 North Dental appoints chief marketing officer
- Physicians vs. prior authorization: 10 updates
- Physicians, not hospitals, are driving practice acquisitions: Study
- ADA backs federal healthcare workforce bill
- Standard Dental Labs plans acquisition of Florida lab
- The states where physicians earn the most after taxes
- Where 6 cardiology advocacy efforts stand now: ACC
- Leadership training, insurance, bonuses and more: What the best dental workplaces offer employees
- UM Health-Sparrow receives record gift for behavioral health hospital
- US psychiatrist workforce to meet 42.8% of projected demand by 2037: Study
- 14 new behavioral health projects to know
- What hospital-employed physicians regret most after an acquisition: Study
- Heartland Dental opens Ohio practice
- Eugene Gastroenterology Consultants opens new ASC
- CRNAs are leaving hospital jobs — where are they going?
- 5 DSOs making headlines
- 2 physicians pay $2.2M to settle claims of medically unnecessary surgical procedures
- Cancer Drug Shortage Renews Calls For Federal Action
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Clinicians' compensation rose 4.3% across 2025: AMGA
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Sanofi under antitrust probe as European Commission kicks off formal proceedings
- Weekly Rundown: Innovaccer, AWS ink strategic collaboration; Mount Sinai adopts Signal 1 for AI management
- Industry Voices—What Pope Leo’s AI encyclical could mean for healthcare: 3 key takeaways for leaders
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
- Efforts To End School Vaccine Mandates Hit a Wall in Florida
- Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
- Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
- Eli Lilly taps AI to bring personal memories to life during its European radio show road trip
- BeOne boosts support for Blood Cancer United with $5M commitment
- Pharma’s Cannes-do attitude sees industry return to triumph
- Biogen launches ‘Ready for More’ HD Spinraza campaign with a focus on how we see SMA
- Senators revive bill targeting expanded methadone access
- DSOs gain new funding to fuel growth: 3 updates
- Montana hospital to end dental services due to financial constraints
- Rhode Island expands reimbursement options for public health hygienists
- 2 behavioral health providers to affiliate under Boundless name
- 5 states targeting Medicaid behavioral health enrollment amid fraud concerns
- Arizona behavioral health clinic suspended from Medicaid amid fraud allegations
- Cassidy's new plan to overhaul 340B: Rebates, contract pharmacy limits and more changes
- With Medicare's GLP-1 'bridge' coming soon, Walmart expands weight management supports for consumers
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict
- Democrats to propose bill capping out-of-pocket costs for Medicare enrollees
- Upside secures $20M series A to expand healthcare-focused housing platform
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Fosun Pharma plots global push beyond oncology, fueled by multi-asset Alzheimer’s strategy
- FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
- Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
- Oracle partners with Theator to expand AI-powered surgical documentation to operating rooms
- Jubilant HollisterStier gets FDA warning letter for quality control problems
- Ionis scores transformational FDA label expansion for Tryngolza
- AstraZeneca spells out a community cancer screening strategy with the YMCA
- Novartis teams up with Becoming rentABLE for its new SMA campaign
- Assort Health scores $120M series C to scale voice AI agent platform for healthcare
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- TigerConnect expands AI-driven platform with new scheduling capabilities
- US health spending set to reach $9T by 2034: CMS report
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- First Stop Health expands weight management program, shares first-year results
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Infinitus launches risk detection system to ensure appropriate patient triage from AI agents
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Some life insurers compete with health insurers on benefits. Here's why
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
The National Vaccine Injury Compensation Program (VICP or NVICP) was established by the 1986 National Childhood Vaccine Injury Act (NCVIA) which was a response to concerns about the diphtheria, pertussis, and tetanus (DPT) vaccine. The Office of Special Masters of the U.S. Court of Federal Claims administers a no-fault system for litigating vaccine injury claims - except for the COVID-19 vaccines. People claiming injuries from the COVID-19 vaccines have to file a claim with the Countermeasures Injury Compensation Program (CICP). Both the NVICP and the CICP are part of the Health Resources & Services Administration (HRSA), but the claims outcomes have been quite different:
Lawsuit: COVID Vaccine Injury Claims Diverted to Unconstitutional 'Kangaroo Court'
A war on terror–era program is the only legal avenue for people seeking compensation for a COVID vaccine injury.
By Christian Britschgi | November 21, 2023People injured by the COVID-19 vaccines are suing the federal government, claiming the federal program they're forced to pursue compensation through is an opaque and unconstitutional "kangaroo court" that unjustly rejects almost all claims it receives.
"It has become far more obvious that the program offers nothing close to due process," says Christopher Dreisbach, the legal affairs director for React19, a patient group of the vaccine injured. "There's not [just] one thing about the program that can be tweaked and be fixed."
React19 is one of several plaintiffs challenging the constitutionality of the Countermeasures Injury Compensation Program (CICP). The other plaintiffs are all individuals whose compensation claims were rejected by the CICP, despite many having diagnoses from their doctors that the severe injuries they experienced within a few hours or days of receiving a COVID-19 vaccine were a result of the vaccine.
Their lawsuit was filed in October in the U.S. District Court for the Western District of Louisiana.
The CICP is currently the only avenue through which those with a COVID-19 vaccine injury can seek compensation.
A mix of federal law and pandemic-era emergency declarations bar the vaccine injured from suing vaccine manufacturers in civil court. Those with a COVID-19 vaccine injury are also prohibited from pursuing compensation through the standard Vaccine Injury Compensation Program (VICP)—a decades-old program that approves about 50 percent of injury claims in an expedited civil court–like process.
Each year, the VICP paid out $200 million in compensation and attorneys' fees, all of which are funded by an excise tax on vaccines.
Contrast that with the CICP, which has paid out a total of around $30,000 compensating eight people claiming a COVID-19 vaccine injury.
That's out of 12,358 total COVID-related claims the CICP has received, according to the latest federal data. The vast majority of those claims are still pending review. Of the 1,600 claims that the CICP has decided, roughly 98 percent were rejected.
The lawsuit filed by React19 and other patients argues the CICP's high rejection rate is a product of a flawed design that includes an exceedingly short deadline for filing for compensation and an impossibly high burden of proof for showing an injury was caused by a vaccine.
People must file a CICP claim within one year of vaccination. That compares to the VICP deadline that gives people three years following the onset of vaccine injury symptoms to file a petition.
"Most of us don't know what's wrong with us for over a year if we can ever get a diagnosis," says Dreisbach, who himself suffered a COVID-19 vaccine injury. "So many in our community don't even know the program even exists."
Of the 1,588 claims CICP has rejected, 933 of them have been for missed deadlines.
In order to get compensation through the CICP, claimants must also show "compelling, reliable, valid, medical, and scientific evidence" that their injury was caused by a COVID-19 vaccine.
By comparison, the VICP has a pretty low threshold for proving a vaccine injury. People who suffered one of several listed "table" injuries soon after receiving their vaccine are presumed to have been injured by the vaccine. Those who suffer a nontable injury need only show by a preponderance of the evidence (i.e., that it's more likely than not) that they were injured by a vaccine.
The higher burden of proof claimants must show the CICP is compounded by the fact that less scientific evidence exists about the effects of the recently invented COVID-19 vaccines.
"When you're talking 40,000 to 60,000 in a study, we know pretty well short-term side effects, but we don't have very much of an idea of what the long-term side effects will be," says Katharine Van Tassel, a law professor at Case Western Reserve School of Law who co-authored a book on the Food and Drug Administration.
Van Tassel says that while vaccines are safe, "we did not have very much time to study [COVID] vaccines, so we know the risk of injury was higher."
The CICP's high burden of proof is compounded by the fact that it's also a purely administrative process, with few guaranteed rights for those seeking compensation. Federal bureaucrats review and decide claims on their own. Claimants have no right to a lawyer to argue their case against the government, no right to submit expert evidence, and no right to appeal a rejected claim to any court.
That all contrasts with the quasi-judicial VICP, where petitioners are guaranteed a lawyer who can submit expert evidence on their behalf and a neutral special master (judge) decides cases. People in the VICP can also appeal a rejected petition all the way up to the U.S. Supreme Court. If that doesn't work, they can then sue vaccine makers in civil court.
In addition to all these problems is the fact that the CICP was, prior to COVID, a little-used program that's arguably been swamped by the huge number of claims it's received.
The CICP was first authorized in 2005 by a piece of war-on-terror legislation intended to encourage companies to produce emergency countermeasures to a bioweapons attack or a similar disaster by shielding them from lawsuits.
Prior to the pandemic, it had received only 500 claims and paid out compensation to only 30 people (mostly for swine flu vaccine injuries).
Van Tassel says that the government is within its powers to suspend people's normal right to sue companies for damages, provided that it also provides anyone claiming an injury "a reasonable alternative remedy" to sue for damages.
The CICP's high standard of proof, short filing deadlines, and lack of any real procedural rights all cause it to fall woefully short of being a "reasonable alternative remedy," she says.
The claims in the lawsuit from React19 and other plaintiffs that the CICP violates the Fifth and Seventh Amendments' guarantees of due process and jury trials are on firm ground, she says. "I think this is a very strong lawsuit," she tells Reason.
There are various congressional efforts to help those with COVID-19 vaccine injuries.
Rep. Lloyd Doggett (D–Texas) has introduced two bills that would shift COVID-19 vaccine injury claimants into the VICP and then modernize the VICP process. Another much more modest bill proposed by Sen. Robert Casey (D–Penn.) would extend the deadline for filing COVID-19 vaccine injury claims.
Last year, Sen. Mike Lee (R–Utah) also introduced a bill that would reform the CICP to make it more like the VICP program, with special masters deciding cases in federal claims court.
None of these efforts have made much headway in Congress, much to the frustration of vaccine-injured advocates.
"Our community needed help yesterday. We've been asking Congress to take action for over two years, our hope is that this lawsuit forces their hand," says Dreisbach.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















